Skip to main content

AGC Pharma Chemicals Europe has completed the investment of the in-house micronization facility which will broaden its service level for customers.

With a feed capacity of 30kg/h (max 50kg/h), the state-of-the-art unit has been designed to handle a wide range of API including HAPI compounds with OEB 4 (OEL band 1-10µg/m3).

The micronizer equipment is a Hosokawa Alpine Multi-Mill, with a dual system which enables wider applications.

The project denominated “Implementation of a new micronization technology for the expansion and diversification of the site capacity” (file nº: ACE002/20/000031) was partially financed by funds from ACCIÓ – Catalonia Trade & Investment of the Generalitat de Catalunya.

The new capability will provide higher flexibility and will offer our customers a complete process integration for their projects.

Contact us for more information.

Latest News

Events & ConventionsAGC Pharma Chemicals at CDMO Live 2025
25th April 2025

AGC Pharma Chemicals at CDMO Live 2025

We are pleased to confirm our participation in CDMO Live 2025, a dedicated partnering event for pharmaceutical outsourcing excellence, taking place on May 7–8 at the World Trade Center Rotterdam,…
Events & ConventionsAGC Pharma Chemicals at Swiss Biotech Day 2025
25th April 2025

AGC Pharma Chemicals at Swiss Biotech Day 2025

AGC Pharma Chemicals is pleased to announce its participation in Swiss Biotech Day 2025, one of Europe’s leading conferences for the biotechnology and life sciences sectors. The event will take…
Events & ConventionsAGC Pharma Chemicals participates in strategic Japan–Catalonia dialogue
8th April 2025

AGC Pharma Chemicals participates in strategic Japan–Catalonia dialogue

On Monday, April 7, AGC Pharma Chemicals CEO, Kadokura Akihiro, recently participated in a working breakfast organized by the Ministry of Business and Labour of the Government of Catalonia, alongside…